Romagnoli Romeo, Baraldi Pier Giovanni, Carrion Maria Dora, Cruz-Lopez Olga, Cara Carlota Lopez, Preti Delia, Tabrizi Mojgan Aghazadeh, Balzarini Jan, Hamel Ernest, Fabbri Enrica, Gambari Roberto
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy.
Lett Drug Des Discov. 2009 Jun 1;6(4):298-303. doi: 10.2174/157018009788452519.
Identification of novel and selective anticancer agents remains an important and challenging goal in pharmacological research. The indole nucleus, frequently encountered as a molecular fragment in natural products and pharmaceutically active compounds, was employed as the initial building block for the synthesis of a series of pyrazino[1,2-a]indoles 1a-k, variably substituted at the 6, 7, 8 and 9-positions. Compound 1e, bearing the methoxy group at the 8-position of the pyrazino[1,2-a]indole nucleus was identified as a novel potent antiproliferative agent against the human chronic myelogenous leukemia K562 cell line, but it was much less active against several other cancer cell lines. Comparison of positional isomers indicated that moving the methoxy group from the 8- to the 7- or 6-position, to furnish compounds 1f and 1g, respectively, yielded inactive compounds. The analysis of structure-activity relationships observed in the series of investigated compounds may represent the basis for the design of more active molecules.
鉴定新型和选择性抗癌药物仍然是药理学研究中的一个重要且具有挑战性的目标。吲哚核作为天然产物和药物活性化合物中的分子片段经常出现,被用作合成一系列吡嗪并[1,2 - a]吲哚1a - k的起始结构单元,这些化合物在6、7、8和9位具有不同的取代基。在吡嗪并[1,2 - a]吲哚核的8位带有甲氧基的化合物1e被鉴定为针对人慢性髓性白血病K562细胞系的新型强效抗增殖剂,但它对其他几种癌细胞系的活性要低得多。位置异构体的比较表明,将甲氧基从8位移至7位或6位分别得到化合物1f和1g,得到的是无活性的化合物。在所研究的一系列化合物中观察到的构效关系分析可能代表了设计更具活性分子的基础。